Literature DB >> 19216923

Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes.

Boris Kovatchev1, Marc Breton, William Clarke.   

Abstract

Scientific and industrial effort is now increasingly focused on the development of closed-loop control systems (artificial pancreas) to control glucose metabolism of people with diabetes, particularly type 1 diabetes mellitus. The primary prerequisite to a successful artificial pancreas, and to optimal diabetes control in general, is the continuous glucose monitor (CGM), which measures glucose levels frequently (e.g., every 5 min). Thus, a CGM collects detailed glucose time series, which carry significant information about the dynamics of glucose fluctuations. However, a CGM assesses blood glucose indirectly via subcutaneous determinations. As a result, two types of analytical problems arise for the retrieval and interpretation of CGM data: (1) the order and the timing of CGM readings and (2) sensor errors, time lag, and deviations from BG need to be accounted for. In order to improve the quality of information extracted from CGM data, we suggest several analytical and data visualization methods. These analyses evaluate CGM errors, assess risks associated with glucose variability, quantify glucose system stability, and predict glucose fluctuation. All analyses are illustrated with data collected using MiniMed CGMS (Medtronic, Northridge, CA) and Freestyle Navigator (Abbott Diabetes Care, Alameda, CA). It is important to remember that traditional statistics do not work well with CGM data because consecutive CGM readings are highly interdependent. In conclusion, advanced analysis and visualization of CGM data allow for evaluation of dynamical characteristics of diabetes and reveal clinical information that is inaccessible via standard statistics, which do not take into account the temporal structure of data. The use of such methods has the potential to enable optimal glycemic control in diabetes and, in the future, artificial pancreas systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216923     DOI: 10.1016/S0076-6879(08)03803-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  4 in total

1.  Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?

Authors:  Chiara Fabris; Stephen D Patek; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2015-08-14

Review 2.  A standard approach to continuous glucose monitor data in pregnancy for the study of fetal growth and infant outcomes.

Authors:  Teri L Hernandez; Linda A Barbour
Journal:  Diabetes Technol Ther       Date:  2012-12-26       Impact factor: 6.118

3.  Chaotic time series prediction for glucose dynamics in type 1 diabetes mellitus using regime-switching models.

Authors:  Mirela Frandes; Bogdan Timar; Romulus Timar; Diana Lungeanu
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

4.  Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes.

Authors:  Boris Kovatchev; Zhaoling Meng; Anna M G Cali; Riccardo Perfetti; Marc D Breton
Journal:  Diabetes Ther       Date:  2020-04-17       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.